Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia
Clinical trial NCT01859637 · TERMINATED
Trial details
- NCT number
- NCT01859637
- Sponsor
- Sandoz
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.